C. Martin

2.2k total citations
13 papers, 894 citations indexed

About

C. Martin is a scholar working on Pathology and Forensic Medicine, Oncology and Surgery. According to data from OpenAlex, C. Martin has authored 13 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 5 papers in Oncology and 3 papers in Surgery. Recurrent topics in C. Martin's work include Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). C. Martin is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). C. Martin collaborates with scholars based in France, Belgium and New Zealand. C. Martin's co-authors include Catherine Thiéblemont, Esteban Cvitkovic, Carmen Kahatt, Étienne Brain, José Jimeno, Yacine Salhi, J. L. Misset, M. Riofrio, Alejandro Yovine and Jean‐Yves Blay and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

C. Martin

13 papers receiving 866 citations

Peers

C. Martin
Yasser Khafaga Saudi Arabia
Mert Başaran Türkiye
T. Chua Canada
Debra Sarasohn United States
Sharon Forsyth United Kingdom
Jennifer Dunlap United States
Yasser Khafaga Saudi Arabia
C. Martin
Citations per year, relative to C. Martin C. Martin (= 1×) peers Yasser Khafaga

Countries citing papers authored by C. Martin

Since Specialization
Citations

This map shows the geographic impact of C. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Martin more than expected).

Fields of papers citing papers by C. Martin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Martin. The network helps show where C. Martin may publish in the future.

Co-authorship network of co-authors of C. Martin

This figure shows the co-authorship network connecting the top 25 collaborators of C. Martin. A scholar is included among the top collaborators of C. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Martin. C. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Mark, Daniel B., Wenqin Pan, Nancy E. Clapp‐Channing, et al.. (2009). Quality of Life after Late Invasive Therapy for Occluded Arteries. New England Journal of Medicine. 360(8). 774–783. 27 indexed citations
3.
Bonnet, Christophe, Georges Fillet, Nicolas Mounier, et al.. (2007). CHOP Alone Compared With CHOP Plus Radiotherapy for Localized Aggressive Lymphoma in Elderly Patients: A Study by the Groupe d’Etude des Lymphomes de l’Adulte. Journal of Clinical Oncology. 25(7). 787–792. 161 indexed citations
4.
Cassier, Philippe A., Sylvie Chabaud, V. Trillet-Lenoir, et al.. (2007). A phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study. Breast Cancer Research and Treatment. 109(2). 343–350. 32 indexed citations
5.
Bouché, Olivier, Marc Ychou, Pascal Burtin, et al.. (2005). Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). Annals of Oncology. 16(9). 1488–1497. 107 indexed citations
6.
François, Éric, Mohamed Hebbar, Jaafar Bennouna, et al.. (2005). A Phase II Trial of Raltitrexed (Tomudex<sup>®</sup>) in Advanced Pancreatic and Biliary Carcinoma. Oncology. 68(4-6). 299–305. 7 indexed citations
8.
Fillet, Georges, Christophe Bonnet, Nicolas Mounier, et al.. (2005). No Role for Chemoradiotherapy When Compared with Chemotherapy Alone in Elderly Patients with Localized Low Risk Aggressive Lymphoma: Final Results of the LNH93-4 GELA Study.. Blood. 106(11). 15–15. 17 indexed citations
9.
Yovine, Alejandro, M. Riofrio, Jean‐Yves Blay, et al.. (2004). Phase II Study of Ecteinascidin-743 in Advanced Pretreated Soft Tissue Sarcoma Patients. Journal of Clinical Oncology. 22(5). 890–899. 261 indexed citations
10.
Thiéblemont, Catherine, Arnulf Mayer, Charles Dumontet, et al.. (2002). Primary Thyroid Lymphoma Is a Heterogeneous Disease. The Journal of Clinical Endocrinology & Metabolism. 87(1). 105–111. 191 indexed citations
12.
Rivas, Carmen, Miguel Á. Piris, Carlos Gamallo, et al.. (1990). Ultrastructure of 26 Cases of Ki-1 Lymphomas: Morphoimmunologic Correlation. Ultrastructural Pathology. 14(5). 381–397. 6 indexed citations
13.
Rivas, Concepción, Miguel Á. Piris, C Bellas, et al.. (1989). [Ki-1 non-Hodgkin's lymphoma. A multihospital study of 21 cases].. PubMed. 184(5). 238–44. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026